Inventor · disambiguated record
Gregory Notte
Also filed as: NOTTE GREGORY · NOTTE GREGORY T
39 granted patents·8 pending applications·364 citations·filing 2007–2025
98Inventor score
Files withGILEAD SCIENCES INC36CORKEY BRITTON5CORKEY BRITTON KENNETH1KOBAYASHI TETSUYA1LEIGHTON JAMES LINCOLN1
Top patents by PatentIndex Score
47 records- 0197US8378108B2Apoptosis signal-regulating kinase inhibitorsGILEAD SCIENCES INC·Filed 2010·Granted Feb 19, 2013·58 cites·10 claims
- 0296US9254284B2Apoptosis signal-regulating kinase inhibitorGILEAD SCIENCES INC·Filed 2014·Granted Feb 9, 2016·27 cites·12 claims
- 0395US9067933B2Apoptosis signal-regulating kinase inhibitorsGILEAD SCIENCES INC·Filed 2013·Granted Jun 30, 2015·25 cites·12 claims
- 0495US8742126B2Apoptosis signal-regulating kinase inhibitorGILEAD SCIENCES INC·Filed 2013·Granted Jun 3, 2014·21 cites·2 claims
- 0594US11548871B2Triazole carbamate pyridyl sulfonamides as LPA receptor antagonists and uses thereofGILEAD SCIENCES INC·Filed 2020·Granted Jan 10, 2023·3 cites·30 claims
- 0694US9371329B2Fused heterocyclic compounds as ion channel modulatorsCORKEY BRITTON·Filed 2014·Granted Jun 21, 2016·26 cites·2 claims
- 0794US8952034B2Fused heterocyclic compounds as ion channel modulatorsCORKEY BRITTON·Filed 2010·Granted Feb 10, 2015·29 cites·18 claims
- 0894US8598360B2Apoptosis signal-regulating kinase inhibitorsCORKEY BRITTON·Filed 2012·Granted Dec 3, 2013·20 cites·4 claims
- 0993US8440665B2Apoptosis signal-regulating kinase inhibitorsCORKEY BRITTON·Filed 2011·Granted May 14, 2013·21 cites·5 claims
- 1092US9750730B2Apoptosis signal-regulating kinase inhibitorGILEAD SCIENCES INC·Filed 2016·Granted Sep 5, 2017·7 cites·10 claims
- 1191US9873682B2Apoptosis signal-regulating kinase inhibitorGILEAD SCIENCES INC·Filed 2017·Granted Jan 23, 2018·6 cites·11 claims
- 1291US9586932B2Apoptosis signal-regulating kinase inhibitorsGILEAD SCIENCES INC·Filed 2015·Granted Mar 7, 2017·7 cites·4 claims
- 1391US9376441B2Substituted pyrrolidines as SYK inhibitorsGILEAD SCIENCES INC·Filed 2014·Granted Jun 28, 2016·17 cites·20 claims
- 1490US12049439B2Sulfinylaminobenzamide and sulfonylaminobenzamide derivativesORSOBIO INC·Filed 2021·Granted Jul 30, 2024·2 cites·50 claims
- 1590US9907790B2Solid forms of an ASK1 inhibitorGILEAD SCIENCES INC·Filed 2017·Granted Mar 6, 2018·6 cites·10 claims
- 1689US9643956B2Solid forms of an ASK1 inhibitorGILEAD SCIENCES INC·Filed 2015·Granted May 9, 2017·9 cites·81 claims
- 1789US9586933B2Processes for preparing ASK1 inhibitorsGILEAD SCIENCES INC·Filed 2015·Granted Mar 7, 2017·5 cites·5 claims
- 1888US8552196B2Apoptosis signal-regulating kinase inhibitorsCORKEY BRITTON·Filed 2012·Granted Oct 8, 2013·8 cites·10 claims
- 1987USRE48150EApoptosis signal-regulating kinase inhibitorsGILEAD SCIENCES INC·Filed 2017·Granted Aug 11, 2020·2 cites·9 claims
- 2087US9333197B2Apoptosis signal-regulating kinase inhibitorNOTTE GREGORY·Filed 2014·Granted May 10, 2016·9 cites·21 claims
- 2187US9169243B2Apoptosis signal-regulating kinase inhibitorsGILEAD SCIENCES INC·Filed 2014·Granted Oct 27, 2015·8 cites·11 claims
- 2286USRE48711EApoptosis signal-regulating kinase inhibitorsGILEAD SCIENCES INC·Filed 2019·Granted Aug 31, 2021·1 cites·10 claims
- 2386US9051313B2Apoptosis signal-regulating kinase inhibitorsGILEAD SCIENCES INC·Filed 2013·Granted Jun 9, 2015·6 cites·9 claims
- 2485US10508100B2Apoptosis signal-regulating kinase inhibitorGILEAD SCIENCES INC·Filed 2019·Granted Dec 17, 2019·2 cites·2 claims
- 2584US11136290B2Sulfinylaminobenzamide and sulfonylaminobenzamide derivativesTHE LIVER COMPANY INC·Filed 2019·Granted Oct 5, 2021·5 cites·43 claims
- 2684US9403782B2Fused heterocyclic compounds as ion channel modulatorsGILEAD SCIENCES INC·Filed 2015·Granted Aug 2, 2016·4 cites·10 claims
- 2783US10005774B2Syk inhibitorsGILEAD SCIENCES INC·Filed 2016·Granted Jun 26, 2018·4 cites·9 claims
- 2883US8703759B2Fused heterocyclic compounds as ion channel modulatorsKOBAYASHI TETSUYA·Filed 2011·Granted Apr 22, 2014·7 cites·25 claims
- 2982US9079901B2Fused heterocyclic compounds as ion channel modulatorsGILEAD SCIENCES INC·Filed 2014·Granted Jul 14, 2015·5 cites·24 claims
- 3081US9115096B2Fused heterocyclic compounds as ion channel modulatorsCORKEY BRITTON KENNETH·Filed 2012·Granted Aug 25, 2015·5 cites·13 claims
- 3180US10946004B2Solid forms of an ASK1 inhibitorGILEAD SCIENCES INC·Filed 2019·Granted Mar 16, 2021·2 cites·8 claims
- 3280US8927582B2Apoptosis signal-regulating kinase inhibitorsGILEAD SCIENCES INC·Filed 2013·Granted Jan 6, 2015·3 cites·6 claims
- 3375US8642798B2Silacycle compounds and methods of use thereofLEIGHTON JAMES LINCOLN·Filed 2007·Granted Feb 4, 2014·3 cites·8 claims
- 3473US12448388B2PRMT5 inhibitors and uses thereofGILEAD SCIENCES INC·Filed 2024·Granted Oct 21, 2025·0 cites·18 claims
- 3573US9908875B2Apoptosis signal-regulating kinase inhibitorsGILEAD SCIENCES INC·Filed 2014·Granted Mar 6, 2018·1 cites·2 claims
- 3672US11999717B2Triazole carbamate pyridyl sulfonamides as LPA receptor antagonists and uses thereofGILEAD SCIENCES INC·Filed 2022·Granted Jun 4, 2024·0 cites·23 claims
- 3766US10307427B2Apoptosis signal-regulating kinase inhibitorsGILEAD SCIENCES INC·Filed 2018·Granted Jun 4, 2019·0 cites·1 claims
- 3865US2025051309A1Mk2 inhibitors and methods of making and using the sameGILEAD SCIENCES INC·Filed 2024·Application pending·0 cites
- 3965US2018099950A1Apoptosis signal-regulating kinase inhibitorGILEAD SCIENCES INC·Filed 2017·Application pending·0 cites
- 4062US2017196844A1Apoptosis signal-regulating kinase inhibitorsGILEAD SCIENCES INC·Filed 2017·Application pending·0 cites
- 4162US2025388585A1Prmt5 inhibitors and uses thereofGILEAD SCIENCES INC·Filed 2025·Application pending·0 cites
- 4260US2024254118A1Prmt5 inhibitors and uses thereofGILEAD SCIENCES INC·Filed 2023·Application pending·0 cites
- 4359US9943521B2Apoptosis signal-regulating kinase inhibitorsGILEAD SCIENCES INC·Filed 2016·Granted Apr 17, 2018·0 cites·8 claims
- 4456US2018243281A1Solid forms of an ask1 inhibitorGILEAD SCIENCES INC·Filed 2018·Application pending·0 cites
- 4552US2015246910A1Apoptosis signal-regulating kinase inhibitorsGILEAD SCIENCES INC·Filed 2015·Application pending·0 cites
- 4651US9682998B2Fused heterocyclic compounds as ion channel modulatorsGILEAD SCIENCES INC·Filed 2016·Granted Jun 20, 2017·0 cites·12 claims
- 4748US2018305315A1Pd-1/pd-l1 inhibitorsGILEAD SCIENCES INC·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Gregory Notte files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →